About ITG

We don't just move products — we move outcomes.

By bridging the gap between cutting-edge U.S. manufacturers and forward-thinking healthcare providers abroad, we enable faster healing, improved patient care, and expanded access to regenerative solutions. Whether you're a clinic in Buenos Aires or a hospital in Bangkok, we ensure you have what you need to treat wounds with confidence and precision.

Who we are

A bridge between U.S. innovation and global patient care.

International Trade Group (ITG) is a global distributor of advanced regenerative wound care technologies. We bring amniotic membrane allografts from trusted U.S. manufacturers to patients and providers across Asia, Latin America, and Europe.

Our mission is simple: help people heal faster, with better outcomes. We work with world-class manufacturers and committed in-country partners to expand access to cutting-edge wound care — serving hospitals, clinics, and providers ready to elevate the standard of care in their region.

With decades of international trade experience, deep regulatory understanding, and a network spanning continents, we are uniquely positioned to deliver these therapies where they are most needed and most underserved.

Our Standards

Four principles, non-negotiable.

01

Ethics

We operate at the intersection of biologics, regulation, and patient safety — where shortcuts are unacceptable. Every partnership is built on full regulatory transparency and rigorous chain of custody.

02

Innovation

We distribute only the technologies we would put on our own families. That means proven outcomes, peer-reviewed evidence, and a curated portfolio of biologics from manufacturers committed to R&D.

03

Regeneration

The goal isn't a closed wound — it's restored tissue, restored function, and a restored life. Regenerative medicine succeeds when the patient walks again, sees again, lives again.

04

Partnership

We treat providers as colleagues and sub-distributors as territory principals. Long-term relationships, not transactional supply. Built on the conviction that everyone wins when patients heal.

Leadership

The principals behind ITG.

Three executives. More than $1 billion in healthcare capital deployed. Operating experience across hospitals, pharmaceuticals, distribution, real estate, and capital markets. ITG is led by people who have built the businesses we serve.

Greg Walker
CEO · Founding Partner

Greg Walker

Greg Walker has built a career in specialty finance structuring, primarily within the healthcare industry, with notable additional successes across hospitality, real estate, and entertainment. He studied finance and business at the University of Houston while playing football under coaches Bill Yeoman and Jack Pardee.

In 1998, Greg transitioned into healthcare, combining his expertise in creative financing with both private and institutional capital. As CEO, he built one of the largest Long-Term Acute Care Hospital companies in the Southwest, expanding into multiple verticals including real estate, pharmacy, DME, and supply chain services — supporting his hospitals as well as other organizations nationwide.

Over the years, Greg has been involved in numerous healthcare ventures spanning laboratories, pharmaceuticals, and medical distribution. He continues to invest in and advise companies across the sector, overseeing investments and managing relationships with leadership teams. He resides in Austin, Texas.

Gustavo Artaza
COO · Founding Partner

Gustavo Artaza

Gustavo Artaza brings over 30 years of executive leadership to ITG. As a founding member of BirdRock Asset Management and Managing Partner of its leadership team, Gustavo is responsible for developing and maintaining key client relationships across family offices, bank and trust companies, and private institutional investors. He serves as Chair of BirdRock's Executive Committee, helping to oversee the firm's strategic direction.

Prior experience includes founding and leading International Studies Abroad, one of the world's largest study abroad providers — establishing the international relationship infrastructure that informs ITG's global distribution model today.

A graduate of the University of Texas at Austin, Gustavo is also founder of Gen1 Research, specializing in pharmaceutical trials. His combination of institutional capital relationships, international operating experience, and pharmaceutical research expertise makes him uniquely suited to ITG's cross-border mission.

Brian Rho
CMO · Founding Partner

Brian Rho

Brian Rho is a distinguished capital markets executive with more than 20 years of experience in structured finance, equity, and debt markets. As CEO of Icon Capital Partners, he specializes in designing strategic financing solutions that advance healthcare providers, life sciences organizations, and medical real estate developments.

Throughout his career, Brian has raised and deployed over $1 billion in capital, including more than $300 million in EB-5 funding for landmark projects. His work has supported the development of healthcare-integrated facilities within high-profile campuses such as Facebook's Seattle headquarters and SoFi Stadium, incorporating medical, sports medicine, and wellness components.

Brian's expertise extends beyond real estate and lending to include Medicare, senior housing, and healthcare reimbursement financing — enabling him to address the sector's most complex financial challenges. He also serves as a trusted advisor to healthcare startups, guiding them through early-stage funding, growth strategies, and capital optimization.

Work with us

Ready to discuss a partnership?

Whether you're a healthcare provider seeking direct access to advanced regenerative wound care, or a sub-distributor exploring territory rights in your region, our principals welcome the conversation directly.

Contact Leadership